WOBBLE GENOMICS
LIVE

Serial Number

97907331

Owner

Wobble Genomics Limited

Attorney

M. Scott Alprin

Filing Date

Apr 25, 2023

Add to watchlist:

No watchlists yet
View on USPTO

WOBBLE GENOMICS Trademark

Serial Number: 97907331

WOBBLE GENOMICS is a trademark filed by Wobble Genomics Limited on April 25, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Wobble Genomics Limited (2 trademarks)

Suite 2, Ground Fl., Orchard Brae House
EDINBURGH EH42HS , GB

Entity Type: 99

Trademark Details

Filing Date

April 25, 2023

Registration Date

Not Registered

Goods & Services

Medical, veterinary, pharmaceutical and clinical diagnostic apparatus for sequencing, sampling, testing, discovery, integration, normalisation, equalisation, measuring and detection of DNA, RNA, nucleic acid, nucleic acid biomarkers, novel genes, isoforms, proteins and protein variants; medical, veterinary, pharmaceutical and clinical diagnostic devices, apparatus, tools and instruments for testing of DNA, RNA, nucleic acid, nucleic acid biomarkers, novel genes, isoforms, proteins and protein variants; biological and microbiological analysis, detection, screening and testing apparatus for medical purposes, namely, surgical devices that facilitate the identification or separation of biologic tissues; medical, veterinary, pharmaceutical and clinical diagnostic apparatus for detecting, identifying, testing and analysing DNA, RNA, proteins, peptides, hormones, metabolic markers and sugars; medical, veterinary, pharmaceutical and clinical diagnostic apparatus, instruments, equipment and devices for use in detection of proteins, peptides, sugars or metabolites; medical, veterinary, pharmaceutical and clinical diagnostic apparatus and instruments for biological, bacteriological, chemical, biochemical and molecular analysis; medical, veterinary, pharmaceutical and clinical diagnostic apparatus, devices and instruments for identifying, measuring, analysing, sequencing or synthesising small molecules, genomes, DNA, RNA or other nucleic acids, proteins, peptides, hormones, metabolic markers and sugars; medical diagnostic and testing apparatus for testing of DNA, RNA, nucleic acid, nucleic acid biomarkers, novel genes, isoforms, proteins and protein variants

Research, development, analysis and testing services relating to DNA, RNA, nucleic acid, nucleic acid biomarkers, novel genes, isoforms, proteins and protein variants; scientific research relating to genetics; genetic research, testing, screening, analysis and engineering; biological and biotechnological research and analysis; biological laboratory services; preparation of biological samples for testing, research and analysis purposes medical, clinical and biological research and development service; research and development in the field of diagnostic preparations; provision of information and data relating to medical research and development conducting clinical trials; research, development and analysis in the field of molecular biology; blood analysis services for scientific and research purposes; laboratory services, namely, research laboratory analysis services in the field of DNA, RNA, nucleic acid, nucleic acid biomarkers, novel genes, isoforms, proteins and protein variants; laboratory testing services, namely, genetic testing for scientific research purposes; structural and functional analysis of genomes; biological, microbiological and viral screening and testing services for scientific research purposes; research, design and development relating to biological and microbiological tests and testing apparatus; diagnostic testing relating to human or animal health for scientific research purposes; analysis and testing of physiological samples for scientific research purposes; medical, scientific and technical research services in the field of DNA, RNA, nucleic acid, nucleic acid biomarkers, novel genes, isoforms, proteins and protein variants; biochemical research and development; chemical analysis for scientific research purposes; pharmaceutical research and development; medical, clinical, biological, scientific and technological research, development, analysis and testing services for scientific research purposes; research, development, analysis and testing services relating to genome sequencing for scientific research purposes; information, advisory and consultancy services relating to all the aforesaid services

Downloadable computer software, laboratory apparatus, instruments, equipment and devices for sequencing, sampling, testing, discovery, integration, normalisation, equalisation, measuring and detection of DNA, RNA, nucleic acid, nucleic acid biomarkers, novel genes, isoforms, proteins and protein variants; Downloadable computer software, laboratory apparatus, instruments, equipment and devices for sequencing, sampling, testing, discovery, integration, normalisation, equalisation, measuring and detection of genetic data, information and materials; Downloadable computer software, laboratory apparatus, instruments, equipment and devices for sequencing, sampling, testing, discovery, integration, normalisation, equalisation, measuring and detection of biological data, information and materials; laboratory equipment, apparatus, devices, systems and downloadable software for DNA, RNA and polynucleic acid sample sequencing, sampling, testing, discovery, integration, normalisation, equalisation, measuring and detection; laboratory equipment, apparatus, devices, systems and downloadable software for preparation, purification, amplification, labelling and analysis of biological samples and materials; laboratory equipment, apparatus, devices, systems and downloadable software, namely, nucleic acid sequencers and synthesizers, instruments for preparation of nucleic acid samples in the form of small sample containers for testing nucleic acid, protein sequencers, genetic analysers, separation apparatus, namely, pre-packed columns for use in separation and purification, nucleic acid purification apparatus, nucleic acid quantitation apparatus, thermal cyclers, cytometry apparatus, protein and peptide synthesizers, mass spectrometers and chromatographs; laboratory equipment for identification and detection of the presence of biologicals or chemicals in a sample; laboratory devices for analysis of genome information; biotechnological apparatus, namely, laboratory apparatus and instruments for extracting DNA, not for medical purposes; nucleic acid sequencers for scientific purposes; microbiological analysis, detection, screening and testing apparatus, namely, laboratory apparatus and computer systems for use in protein purification; apparatus and devices for carrying out diagnostic tests, namely, diagnostic apparatus for research laboratory use for DNA analysis; laboratory apparatus, devices and instruments for identifying, measuring, analysing, sequencing or synthesising small molecules, genomes, DNA, RNA or other nucleic acids, proteins, peptides, hormones, metabolic markers and sugars; apparatus and devices for use in DNA, RNA, protein and polynucleic acid sequencing

Medical sequencing, sampling, testing, discovery, integration, normalisation, equalisation, measuring and detection services relating to DNA, RNA, nucleic acid, nucleic acid biomarkers, novel genes, isoforms, proteins and protein variants; animal tissue bank services; cryotherapy services; collection and preservation of animal genetic materials; revival and restoration of animal genetic materials; veterinary services relating to testing of DNA, RNA, nucleic acid, nucleic acid biomarkers, novel genes, isoforms, proteins and protein variants; veterinary services relating to the treatment and processing of stem cells; genetic testing of animals for diagnostic and treatment purposes; medical diagnostic services; medical screening and testing services; medical monitoring and reporting services; optical imaging for medical diagnostic use; medical testing for diagnostic or treatment purposes; medical data services; DNA and RNA testing, screening, extraction and purification services for medical purposes; medical evaluation services; medical screening, testing, monitoring, reporting and analysis services relating to genome sequencing; medical services in the nature of amplifying, labelling, detecting, analysing and sequencing nucleic acids; medical screening, testing, monitoring, reporting and analysis services relating to cells, tissues, gene expressions, gene and genome sequences, genome annotation, genome mapping, genome interaction and annotation, all for medical purposes; information, advisory and consultancy services relating to all the aforesaid services

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 8, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 8, 2026 CRFA
ASSIGNED TO LIE
Jun 8, 2026 ALIE
NOTICE OF REVIVAL - E-MAILED
Jun 4, 2026 NREV
PETITION GRANTED - RESPONSE RECEIVED
Jun 4, 2026 PGRR
ASSIGNED TO PETITION STAFF
Jun 3, 2026 APET
TEAS PETITION TO REVIVE RECEIVED
Apr 27, 2026 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 26, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 26, 2026 ABN2
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Nov 12, 2025 GNS1
SUBSEQUENT FINAL EMAILED
Nov 12, 2025 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Nov 12, 2025 CFRC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 14, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 13, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 13, 2025 GNSL
SUSPENSION LETTER WRITTEN
Feb 13, 2025 CNSL
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 4, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 4, 2024 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 10, 2024 GNFN
FINAL REFUSAL E-MAILED
Sep 10, 2024 GNFR
FINAL REFUSAL WRITTEN
Sep 10, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 1, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 31, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 31, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 29, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 29, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 31, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 31, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 31, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 22, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 23, 2023 NWOS
NEW APPLICATION ENTERED
Apr 28, 2023 NWAP